DoD Melanoma, Idea Award | HT942525MRPIA

Opportunity Information: Apply for HT942525MRPIA

The DoD Melanoma, Idea Award (Funding Opportunity Number HT942525MRPIA) is a discretionary research grant offered through the Department of the Army, U.S. Army Medical Research Acquisition Activity (USAMRAA), under CFDA 12.420. It is designed to push forward genuinely new directions in melanoma research by backing projects that are innovative, exploratory, and intentionally high-risk, with the understanding that these kinds of ideas can also be high-reward if they work. The program is clearly positioned for concepts that challenge existing assumptions or open up nontraditional approaches, rather than incremental extensions of prior work.

A defining expectation of this award is strong novelty. The solicitation emphasizes that innovation should be central to the project, meaning reviewers will likely be looking for a clear argument that the proposed approach is distinct from the current state of the field and not simply a repackaging of established methods. The award is oriented toward early-stage hypothesis testing and concept validation. By the end of the funding period, a successful project should have established proof of principle and generated enough preliminary evidence to justify and support a larger follow-on grant from DoD or another funding source. In other words, this mechanism is meant to help investigators cross the gap between a bold idea and the first credible dataset that shows the idea can work.

The application process is structured as a two-step submission. Applicants must first submit a pre-application, and only those who receive an invitation are allowed to submit a full application. This setup typically means the pre-application functions as a screening stage where the sponsor evaluates whether the concept fits the award’s goals, particularly around innovation and potential impact, before requiring the time and effort of a full proposal. Applicants should plan timelines accordingly because a strong pre-application is not optional; it is the gateway to full consideration.

Another distinctive feature is that preliminary data are discouraged. That signals the program is intentionally making room for concepts that may not yet have a deep supporting dataset, which aligns with the high-risk, exploratory nature of the award. The implicit tradeoff is that the proposal will likely be judged heavily on the clarity and logic of the scientific rationale, the strength of the experimental plan, the feasibility of reaching proof of principle within the period of performance, and the potential for meaningful payoff if the approach succeeds. Investigators will generally need to demonstrate credibility through sound design, strong methodological justification, and appropriate expertise rather than leaning on extensive prior results.

The opportunity is listed as unrestricted in terms of eligible applicants, indicating broad eligibility rather than limiting submissions to a narrow set of institution types. The closing date is October 1, 2025, and the opportunity anticipates making about nine awards. An award ceiling is not stated in the provided summary, so applicants would need to consult the full announcement for budget limits, performance period, and any cost restrictions or required budget categories.

Overall, this is a melanoma-focused seed-style mechanism meant to accelerate bold, unconventional ideas to the point where they have proof of principle and early data strong enough to compete for larger-scale funding. The most competitive submissions are likely to be those that clearly articulate what is new, why it matters for melanoma, what specific proof-of-principle milestone will be achieved, and how the resulting outcomes will position the team for a subsequent, more definitive research award.

• The Dept. of the Army -- USAMRAA in the science and technology and other research and development sector is offering a public funding opportunity titled "DoD Melanoma, Idea Award" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 12.420.
• This funding opportunity was created on 2025-05-14.
• Applicants must submit their applications by 2025-10-01. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• The number of recipients for this funding is limited to 9 candidate(s).
• Eligible applicants include: Unrestricted.

Apply for HT942525MRPIA

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: